250 related articles for article (PubMed ID: 16842970)
1. Regulation of protein kinase B activity by PTEN and SHIP2 in human prostate-derived cell lines.
Sharrard RM; Maitland NJ
Cell Signal; 2007 Jan; 19(1):129-38. PubMed ID: 16842970
[TBL] [Abstract][Full Text] [Related]
2. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast.
RodrÃguez-Escudero I; Roelants FM; Thorner J; Nombela C; Molina M; Cid VJ
Biochem J; 2005 Sep; 390(Pt 2):613-23. PubMed ID: 15913452
[TBL] [Abstract][Full Text] [Related]
3. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
[TBL] [Abstract][Full Text] [Related]
4. Imatinib mesilate-induced phosphatidylinositol 3-kinase signalling and improved survival in insulin-producing cells: role of Src homology 2-containing inositol 5'-phosphatase interaction with c-Abl.
Mokhtari D; Al-Amin A; Turpaev K; Li T; Idevall-Hagren O; Li J; Wuttke A; Fred RG; Ravassard P; Scharfmann R; Tengholm A; Welsh N
Diabetologia; 2013 Jun; 56(6):1327-38. PubMed ID: 23462796
[TBL] [Abstract][Full Text] [Related]
5. SHIP2 inhibition alters redox-induced PI3K/AKT and MAP kinase pathways via PTEN over-activation in cervical cancer cells.
Azzi A
FEBS Open Bio; 2020 Oct; 10(10):2191-2205. PubMed ID: 32881386
[TBL] [Abstract][Full Text] [Related]
6. Serum withdrawal-induced accumulation of phosphoinositide 3-kinase lipids in differentiating 3T3-L6 myoblasts: distinct roles for Ship2 and PTEN.
Mandl A; Sarkes D; Carricaburu V; Jung V; Rameh L
Mol Cell Biol; 2007 Dec; 27(23):8098-112. PubMed ID: 17893321
[TBL] [Abstract][Full Text] [Related]
7. 5' phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells.
Taylor V; Wong M; Brandts C; Reilly L; Dean NM; Cowsert LM; Moodie S; Stokoe D
Mol Cell Biol; 2000 Sep; 20(18):6860-71. PubMed ID: 10958682
[TBL] [Abstract][Full Text] [Related]
8. Loss of PTEN expression does not contribute to PDK-1 activity and PKC activation-loop phosphorylation in Jurkat leukaemic T cells.
Freeley M; Park J; Yang KJ; Wange RL; Volkov Y; Kelleher D; Long A
Cell Signal; 2007 Dec; 19(12):2444-57. PubMed ID: 17826953
[TBL] [Abstract][Full Text] [Related]
9. PTEN and Other PtdIns(3,4,5)P
Csolle MP; Ooms LM; Papa A; Mitchell CA
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276499
[TBL] [Abstract][Full Text] [Related]
10. INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC.
Reed DE; Shokat KM
Mol Cancer Res; 2017 Jun; 15(6):765-775. PubMed ID: 28196852
[TBL] [Abstract][Full Text] [Related]
11. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
[TBL] [Abstract][Full Text] [Related]
12. PI(3,4,5)P3 and PI(3,4)P2 levels correlate with PKB/akt phosphorylation at Thr308 and Ser473, respectively; PI(3,4)P2 levels determine PKB activity.
Ma K; Cheung SM; Marshall AJ; Duronio V
Cell Signal; 2008 Apr; 20(4):684-94. PubMed ID: 18249092
[TBL] [Abstract][Full Text] [Related]
13. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.
Shukla S; Maclennan GT; Hartman DJ; Fu P; Resnick MI; Gupta S
Int J Cancer; 2007 Oct; 121(7):1424-32. PubMed ID: 17551921
[TBL] [Abstract][Full Text] [Related]
14. Impact of lipid phosphatases SHIP2 and PTEN on the time- and Akt-isoform-specific amelioration of TNF-alpha-induced insulin resistance in 3T3-L1 adipocytes.
Ikubo M; Wada T; Fukui K; Ishiki M; Ishihara H; Asano T; Tsuneki H; Sasaoka T
Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E157-64. PubMed ID: 19001549
[TBL] [Abstract][Full Text] [Related]
15. Abnormal elevated PTEN expression in the mouse antrum of a model of GIST Kit(K641E/K641E).
Deneubourg L; Ralea S; Gromova P; Parsons R; Vanderwinden JM; Erneux C
Cell Signal; 2011 Nov; 23(11):1857-68. PubMed ID: 21757001
[TBL] [Abstract][Full Text] [Related]
16. PTEN and SHIP2 regulates PI3K/Akt pathway through focal adhesion kinase.
Gupta A; Dey CS
Mol Cell Endocrinol; 2009 Oct; 309(1-2):55-62. PubMed ID: 19501627
[TBL] [Abstract][Full Text] [Related]
17. SH2-containing inositol phosphatase 2 predominantly regulates Akt2, and not Akt1, phosphorylation at the plasma membrane in response to insulin in 3T3-L1 adipocytes.
Sasaoka T; Wada T; Fukui K; Murakami S; Ishihara H; Suzuki R; Tobe K; Kadowaki T; Kobayashi M
J Biol Chem; 2004 Apr; 279(15):14835-43. PubMed ID: 14744864
[TBL] [Abstract][Full Text] [Related]
18. PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes.
Tang X; Powelka AM; Soriano NA; Czech MP; Guilherme A
J Biol Chem; 2005 Jun; 280(23):22523-9. PubMed ID: 15824124
[TBL] [Abstract][Full Text] [Related]
19. Differential mechanisms of constitutive Akt/PKB activation and its influence on gene expression in pancreatic cancer cells.
Matsumoto J; Kaneda M; Tada M; Hamada J; Okushiba S; Kondo S; Katoh H; Moriuchi T
Jpn J Cancer Res; 2002 Dec; 93(12):1317-26. PubMed ID: 12495471
[TBL] [Abstract][Full Text] [Related]
20. PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas.
Nakamura JL; Karlsson A; Arvold ND; Gottschalk AR; Pieper RO; Stokoe D; Haas-Kogan DA
J Neurooncol; 2005 Feb; 71(3):215-22. PubMed ID: 15735908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]